The Association of Medical Research Charities (AMRC) has published its annual report which examines the impact that medical research charities across the UK have on the research sector.
Over 150 charities are members of the AMRC, including LMRUK, with 89 dedicated to funding new research into understanding the body, health and diseases, and 85 funding transitional research turning discoveries into practical applications.
LMRUK specialises in funding novel new research into the diagnosis of blood cancers and more effective treatments of the condition, particularly through the use of stem cells.
The report found that £1.7 billion was spent by AMRC members on medical research in the UK for the financial year ending in 2023, and over £16 billion has been invested over the last ten years.
This figure shows a significant continued investment into medical research to help and improve lives, although 50 percent of AMRC members think that the cost-of-living crisis and the rise in inflation has or will cause a decrease in their research spend.
Our Operations Director, Dr Joanna Tilley said: “We’re proud to be a member of the AMRC and to join over 150 charities across the country to continue investing in potentially lifesaving research.
“Each year – through our annual Research Grant Scheme – we fund new research projects to help better understand the causes of blood cancers and explore new, more targeted treatments to help protect the next generation from this disease.
“Last year, over 1,300 clinical research studies or trials were funded by AMRC members, which is a reflection of the vital role research charities play in helping to understand and cure diseases and illnesses.”
To read the AMRC’s full ‘Our Sector’s Footprint’ report, visit: www.amrc.org.uk/our-sectors-footprint-in-2023.
